| RS2515675063 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515675708 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515679217 |
HNF4A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515679716 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2515679836 |
HNF4A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515680075 |
HNF4A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515680101 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2515681435 |
ITCH
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515685116 |
NFATC2
|
Health Risk |
Pathogenic |
Joint contractures, osteochondromas |
| RS2515692811 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2515695390 |
ITCH
|
Health Risk |
Likely pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515699364 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2515699379 |
HNF4A
|
Health Risk |
Likely pathogenic |
— |
| RS2515708304 |
CD40
|
Health Risk |
Pathogenic |
— |
| RS2515708347 |
CD40
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS2515708636 |
SALL4
|
Health Risk |
Likely pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515710056 |
DPM1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type 1E |
| RS2515710157 |
DPM1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type 1E |
| RS2515713794 |
HNF4A
|
Health Risk |
Pathogenic |
— |
| RS2515713821 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515714538 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS2515714649 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515714702 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515714748 |
SALL4
|
Health Risk |
Likely pathogenic |
SALL4-related disorder, SALL4-related disorder |
| RS2515714792 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS2515714934 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515714969 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515715730 |
SALL4
|
Health Risk |
Pathogenic |
— |
| RS2515716088 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515716591 |
SALL4
|
Health Risk |
Likely pathogenic |
SALL4-related disorder, SALL4-related disorder |
| RS2515716795 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, SALL4-related disorder |
| RS2515718577 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS2515725 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, Inborn genetic diseases |
| RS2515728402 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2515729824 |
CD40
|
Health Risk |
Likely pathogenic |
— |
| RS2515738438 |
NLRP7
|
Health Risk |
Likely pathogenic |
NLRP7-related disorder, NLRP7-related disorder |
| RS2515763229 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2515763244 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515767748 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2515767848 |
ABHD12
|
Health Risk |
Likely pathogenic |
PHARC syndrome, PHARC syndrome |
| RS2515770212 |
ABHD12
|
Health Risk |
Likely pathogenic |
— |
| RS2515791028 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS2515793320 |
CFAP61
|
Health Risk |
Pathogenic |
Spermatogenic failure 84, Spermatogenic failure 84 |
| RS2515795221 |
NCR1;NLRP7
|
Health Risk |
Pathogenic |
Hydatidiform mole, recurrent |
| RS2515805050 |
CFAP61
|
Health Risk |
Pathogenic |
Spermatogenic failure 84, Spermatogenic failure 84 |
| RS2515817309 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2515818511 |
TNNC2
|
Health Risk |
Pathogenic |
Congenital myopathy 15, Congenital myopathy 15 |
| RS2515819804 |
ITCH
|
Health Risk |
Likely pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515866863 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515907041 |
LDLR
|
Health Risk |
Pathogenic |
— |
| RS2515907266 |
LDLR
|
Health Risk |
Likely pathogenic |
Homozygous familial hypercholesterolemia, Homozygous familial hypercholesterolemia |
| RS2515907293 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515915787 |
TUBB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia, isolated |
| RS2515915876 |
TUBB1
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, isolated |
| RS2515933527 |
CAMK2D
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2515937569 |
ODAD1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515940072 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515944973 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515945576 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515945816 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515950018 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515950149 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515955334 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515955858 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515956113 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515956176 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515964841 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515965214 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515965305 |
LDLR
|
Health Risk |
Pathogenic |
— |
| RS2515965640 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515966234 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515966675 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515966911 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS2515967726 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515968095 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515968304 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515968602 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515968704 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515968718 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515968810 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515968980 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515969112 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515973844 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515977526 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515977793 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515978372 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515979618 |
LAMA5
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, IIa 26 |
| RS2515980140 |
TAF4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2515981247 |
LAMA5
|
Health Risk |
Pathogenic |
Nephrotic syndrome, IIa 26 |
| RS2515981533 |
TAF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2515981638 |
TAF4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2515985503 |
TAF4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2515989112 |
TAF4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2515989975 |
LDLR
|
Health Risk |
Likely pathogenic |
LDLR-related disorder, LDLR-related disorder |
| RS2515990431 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS2515990772 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515990989 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS2515992645 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2515995236 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515995812 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |